NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation - PubMed (original) (raw)

NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation

L C Sambucetti et al. EMBO J. 1989.

Abstract

The expression of cytomegalovirus alpha (immediate early) genes is under control of an enhancer that carries signals for strong constitutive expression as well as response elements for transactivation by viral proteins. We have used synthetic oligonucleotides representing the 16, 18 and 19 bp repeat elements within the enhancer to investigate the role of virus-induced cellular transcription factors in enhancer activation. We show that the transcription factor NF-kappa B, which binds to the 18 bp repeat, plays a central role in enhancer activation in infected human fibroblasts and that activation is mediated by the product of the viral gene ie1. The simian immunodeficiency virus kappa B site can functionally substitute for the 18 bp element in transient transactivation assays and can also compete efficiently for specific binding to the 18 bp repeat element in vitro. Point mutations in the NF-kappa B site within the 18 bp element disrupt ie1-mediated transactivation and binding. We have found that the characteristics of the 18 bp binding factor from human fibroblasts are indistinguishable from NF-kappa B induced by phorbol ester plus mitogen treatment of T lymphocytes, as determined by gel mobility shift assay as well as protection of the binding site from chemical cleavage. Furthermore, T cell stimulation mediates activation of the viral enhancer via kappa B sites, an observation that may be important in the interaction of cytomegalovirus with the naturally infected human host. Thus, NF-kappa B plays a central role as a target for enhancer activation via viral and cellular factors.

PubMed Disclaimer

Cited by

Activation of cJUN N-terminal kinase by herpes simplex virus type 1 enhances viral replication.
McLean TI, Bachenheimer SL. McLean TI, et al. J Virol. 1999 Oct;73(10):8415-26. doi: 10.1128/JVI.73.10.8415-8426.1999. J Virol. 1999. PMID: 10482593 Free PMC article.
Multiple mechanisms are implicated in the regulation of NF-kappa B activity during human cytomegalovirus infection.
Kowalik TF, Wing B, Haskill JS, Azizkhan JC, Baldwin AS Jr, Huang ES. Kowalik TF, et al. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1107-11. doi: 10.1073/pnas.90.3.1107. Proc Natl Acad Sci U S A. 1993. PMID: 8381532 Free PMC article.
Human cytomegalovirus IE1 protein enhances herpes simplex virus type 1-induced syncytial formation in U373MG cells.
Shin KC, Park CG, Hwang ES, Cha CY. Shin KC, et al. J Korean Med Sci. 2008 Dec;23(6):1046-52. doi: 10.3346/jkms.2008.23.6.1046. Epub 2008 Dec 24. J Korean Med Sci. 2008. PMID: 19119451 Free PMC article.
Longitudinal, noninvasive imaging of T-cell effector function and proliferation in living subjects.
Patel MR, Chang YF, Chen IY, Bachmann MH, Yan X, Contag CH, Gambhir SS. Patel MR, et al. Cancer Res. 2010 Dec 15;70(24):10141-9. doi: 10.1158/0008-5472.CAN-10-1843. Cancer Res. 2010. PMID: 21159636 Free PMC article.

References

1. Proc Natl Acad Sci U S A. 1986 Jan;83(2):295-8 - PubMed
1. Virology. 1989 Oct;172(2):584-600 - PubMed
1. Cell. 1986 Aug 29;46(5):705-16 - PubMed
1. J Virol. 1986 Oct;60(1):29-36 - PubMed
1. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6682-6 - PubMed

NF-kappa B activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation - PubMed (original) (raw)